SCHEMBL29409170

SCHEMBL29409170

O=C(O)CCNc1cc(N2CCOCC2)nc(-c2ccccn2)n1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM6A O15550 5/20 0.79
KDM5B Q9UGL1 4/20 0.79
KDM5A P29375 3/20 0.79
KDM5C P41229 3/20 0.79
KDM6B O15054 3/20 0.79
KDM2B Q8NHM5 3/20 0.79
KDM4C Q9H3R0 3/20 0.79
PHF8 Q9UPP1 3/20 0.79
KDM4A O75164 2/20 0.79
KDM4B O94953 2/20 0.79
KDM3A Q9Y4C1 2/20 0.79
KDM4E B2RXH2 2/20 0.79
CHRNA1 P02708 2/20 0.79
MAOB P27338 2/20 0.79
OPRM1 P35372 2/20 0.79
OPRK1 P41145 2/20 0.79
PDE4B Q07343 2/20 0.79
SCN5A Q14524 2/20 0.79
MAOA P21397 1/20 0.79
KCNH2 Q12809 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10156432 1.00 KDM6A (0.79) KDM6AKDM5BKDM5AKDM5CKDM6B
SCHEMBL18492979 0.91 KDM6A (0.83) KDM6AKDM5BKDM5AKDM5CKDM6B
SCHEMBL29409224 0.91 KDM6A (0.83) KDM6AKDM5BKDM5AKDM5CKDM6B
SCHEMBL29353127 0.88 KDM6B (1.00) KDM6AKDM5BKDM5AKDM5CKDM6B
SCHEMBL10157115 0.88 KDM6B (1.00) KDM6AKDM5BKDM5AKDM5CKDM6B
SCHEMBL29371558 0.88 KDM6B (1.00) KDM6AKDM5BKDM5AKDM5CKDM6B
SCHEMBL10157593 0.87 KDM6A (0.81) KDM6AKDM5BKDM5AKDM5CKDM6B
SCHEMBL10156436 0.86 KDM6B (0.76) KDM6AKDM5BKDM5AKDM5CKDM6B
SCHEMBL10157135 0.85 KDM6A (0.74) KDM6AKDM5BKDM5AKDM5CKDM6B
SCHEMBL17899150 0.79 KDM6B (0.84) KDM6AKDM5BKDM5AKDM5CKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3962559-A1 METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES University of Houston System (US) 2022-03-09 EP disclosed